|
Volumn 285, Issue 24, 2001, Pages 3087-3089
|
Relapse of depression after electroconvulsive therapy [1]
a b b c |
Author keywords
Antidepressive agents; Electroconvulsive therapy; Recurrence; Treatment outcome
|
Indexed keywords
ANTIDEPRESSANT AGENT;
CITALOPRAM;
FLUOXETINE;
PAROXETINE;
SEROTONIN UPTAKE INHIBITOR;
SERTRALINE;
CLINICAL TRIAL;
DEPRESSION;
DISEASE SEVERITY;
ELECTROCONVULSIVE THERAPY;
HUMAN;
LETTER;
LONG TERM CARE;
METHODOLOGY;
PRIORITY JOURNAL;
PSYCHOPHARMACOTHERAPY;
RELAPSE;
REMISSION;
SEIZURE THRESHOLD;
STANDARDIZATION;
TREATMENT FAILURE;
TREATMENT OUTCOME;
MAJOR DEPRESSION;
MULTIMODALITY CANCER THERAPY;
NOTE;
RECURRENT DISEASE;
ANTIDEPRESSIVE AGENTS;
COMBINED MODALITY THERAPY;
DEPRESSIVE DISORDER, MAJOR;
ELECTROCONVULSIVE THERAPY;
HUMANS;
RECURRENCE;
RESEARCH DESIGN;
SEROTONIN UPTAKE INHIBITORS;
REMISSION INDUCTION;
|
EID: 0035958294
PISSN: 00987484
EISSN: None
Source Type: Journal
DOI: 10.1001/jama.285.24.3087 Document Type: Letter |
Times cited : (4)
|
References (0)
|